US 10493087
Sialylation-increasing therapies for diseases associated with oxidative stress
granted A61KA61K31/7008A61K31/7012
Quick answer
US patent 10493087 (Sialylation-increasing therapies for diseases associated with oxidative stress) held by The United States of America, as represented by National Institute of Health expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by National Institute of Health
- Grant date
- Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/7008, A61K31/7012, A61K31/702, A61K31/7088